(Q30970102)

2

1 reference

27 June 2017

Hartl I

3

1 reference

27 June 2017

Voelker B

4

1 reference

27 June 2017

Chadwick MP

5

1 reference

27 June 2017

Russell SJ

6

1 reference

27 June 2017

Cichutek K

7

1 reference

27 June 2017

Buchholz CJ

The emerging fields of suicide gene therapy and virotherapy.

8

1 reference

27 June 2017

1 August 2003

1 reference

27 June 2017

1 reference

27 June 2017

10

1 reference

27 June 2017

1370-1380

1 reference

27 June 2017

16

1 reference

27 June 2017

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302007

Retargeting gene delivery using surface-engineered retroviral vector particles.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302007

Targeting retroviral vectors to CD34-expressing cells: binding to CD34 does not catalyze virus-cell fusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302007

Targeting retroviral vectors to vascular lesions by genetic engineering of the MoMLV gp70 envelope protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302007

Retroviral vectors preloaded with a viral receptor-ligand bridge protein are targeted to specific cell types

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302007

Selective transduction of protease-rich tumors by matrix-metalloproteinase-targeted retroviral vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302007

In vivo selection of protease cleavage sites from retrovirus display libraries

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302007

Modifying the host range properties of retroviral vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302007

Matrix metalloproteinases in tumour invasion and metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302007

Matrix metalloproteinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302007

Matrix metalloproteinases: effectors of development and normal physiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302007

Matrix metalloproteinases in cancer invasion, metastasis and angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302007

Antibody engineering by parsimonious mutagenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302007

Claudin promotes activation of pro-matrix metalloproteinase-2 mediated by membrane-type matrix metalloproteinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302007

Molecular breeding of viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302007

Altering retroviral tropism using a random-display envelope library

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302007

Codon-based mutagenesis using dimer-phosphoramidites

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302007

Targeting of tumor cells by cell surface urokinase plasminogen activator-dependent anthrax toxin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302007

Efficient cell infection by Moloney murine leukemia virus-derived particles requires minimal amounts of envelope glycoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302007

Overview of matrix metalloproteinase expression in cultured human cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302007

A unique substrate recognition profile for matrix metalloproteinase-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302007

Masking of retroviral envelope functions by oligomerizing polypeptide adaptors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302007

Genomic stability of murine leukemia viruses containing insertions at the Env-3' untranslated region boundary

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302007

Analysis of mutation in human cells by using an Epstein-Barr virus shuttle system

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302007

A transient three-plasmid expression system for the production of high titer retroviral vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302007

Retroviral retargeting by envelopes expressing an N-terminal binding domain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302007

inferred from DOI database lookup

7 January 2021

based on heuristic

A gene delivery system activatable by disease-associated matrix metalloproteinases

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302007

inferred from DOI database lookup

7 January 2021

based on heuristic

High-titer packaging cells producing recombinant retroviruses resistant to human serum

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302007